Results 141 to 150 of about 3,869,430 (327)

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Etcetera [PDF]

open access: yes, 2018
This section contains items whose aim is to supplement the articles and other work published in this volume of Sociology between the Gaps.

core   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Supplement [PDF]

open access: yesJournal of Athletic Training, 2019
openaire   +2 more sources

Safety Aspects of the Use of Quercetin as a Dietary Supplement

open access: yesMolecular Nutrition & Food Research, 2018
Susanne Andres   +6 more
semanticscholar   +1 more source

Order in the Classroom [PDF]

open access: yes, 2003
The School of Law\u27s multifaceted advocacy programs supplement traditional classroom learning by offering students opportunities to apply their legal knowledge in the ...
Leary, Betty L
core   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy